Φορτώνει......
Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor α antibody
Few patients with Behçet's syndrome have gastrointestinal ulceration. Such patients are difficult to treat and have a higher mortality. Faced with refractory symptoms in two patients with intestinal Behçet's, we used the tumour necrosis factor α (TNF-α) monoclonal antibody infliximab to in...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2001
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1728519/ https://ncbi.nlm.nih.gov/pubmed/11600479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.49.5.725 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|